Loading clinical trials...
Loading clinical trials...
The Center for Enhancing Treatment & Utilization for Depression and Emergent Suicidality Phase 2-Study 3-BRITEPath
Conditions
Interventions
BRITEPath
Treatment As Usual (TAU)
Locations
6
United States
Henry Ford Health System
Detroit, Michigan, United States
Northwell Hospital
Hyde Park, New York, United States
Children's Community Pediatrics (CCP-Moon) of Children's Hospital of Pittsburgh of UPMC
Moon Township, Pennsylvania, United States
STAR- Center
Pittsburgh, Pennsylvania, United States
Children's Community Pediatrics (CCP- Wexford) of Children's Hospital of Pittsburgh of UPMC
Wexford, Pennsylvania, United States
Seattle Children's Hospital
Seattle, Washington, United States
Start Date
November 5, 2020
Primary Completion Date
March 23, 2022
Completion Date
July 31, 2022
Last Updated
June 5, 2023
NCT07073963
NCT05988489
NCT05883540
NCT06373718
NCT07538427
NCT06790641
Lead Sponsor
University of Pittsburgh
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions